Literature DB >> 11520802

Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation.

A E Morelli1, A F Zahorchak, A T Larregina, B L Colvin, A J Logar, T Takayama, L D Falo, A W Thomson.   

Abstract

Although it is known that dendritic cells (DCs) produce cytokines, there is little information about how cytokine synthesis is regulated during DC development. A range of cytokine mRNA/proteins was analyzed in immature (CD86-) or mature (CD86+) murine bone marrow (BM)- derived DCs. Highly purified, flow-sorted, immature DCs exhibited higher amounts of interleukin-1alpha (IL-1alpha), IL-1beta, tumor necrosis factor-alpha (TNF-alpha), transforming growth factor beta1 (TGF-beta1), and macrophage migration inhibitory factor (MIF) mRNA/protein than mature DCs. After differentiation, DC up-regulated the levels of IL-6 and IL-15 mRNA/protein and synthesized de novo mRNA/protein for IL-12p35, IL-12p40, and IL-18. Although immature BM-derived DCs did not stimulate naive allogeneic T cells, mature DCs elicited a mixed population of T helper (Th) 1 (mainly) and Th2 cells in 3d-mixed leukocyte reactions. CD86+ BM DCs switched to different cytokine patterns according to whether they were terminally differentiated by lipopolysaccharide (LPS) or CD40 ligation. Although both stimuli increased IL-6, IL-12p40, IL-15, and TNF-alpha mRNA/protein levels, only LPS up-regulated transcription of IL-1alpha, IL-1beta, IL-12p35, and MIF genes. Although LPS and CD40 cross-linking increased the T-cell allostimulatory function of BM DCs, only LPS stimulation shifted the balance of naive Th differentiation to Th1 cells, a mechanism dependent on the up-regulation of IL-12p35 and not of IL-23. These results demonstrate that, depending on the stimuli used to terminally mature BM DCs, DCs synthesize a different pattern of cytokines and exhibit distinct Th cell-driving potential.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520802     DOI: 10.1182/blood.v98.5.1512

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  53 in total

1.  Both exogenous and endogenous interleukin-10 affects the maturation of bone-marrow-derived dendritic cells in vitro and strongly influences T-cell priming in vivo.

Authors:  Claus Haase; Trine N Jørgensen; Birgitte K Michelsen
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo.

Authors:  N M Rogers; S Kireta; P T H Coates
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

3.  mTORC2 Deficiency in Myeloid Dendritic Cells Enhances Their Allogeneic Th1 and Th17 Stimulatory Ability after TLR4 Ligation In Vitro and In Vivo.

Authors:  Dàlia Raïch-Regué; Brian R Rosborough; Alicia R Watson; Mandy J McGeachy; Hēth R Turnquist; Angus W Thomson
Journal:  J Immunol       Date:  2015-04-03       Impact factor: 5.422

4.  Involvement of interleukin-18 in the pathogenesis of human eosinophilic esophagitis.

Authors:  Rituraj Niranjan; Priya Rajavelu; Sathisha Upparahalli Ventateshaiah; Jai Shankar Shukla; Asifa Zaidi; Siddesha Jalahalli Mariswamy; Jochen Mattner; Ilana Fortgang; Monika Kowalczyk; Luis Balart; Anshi Shukla; Anil Mishra
Journal:  Clin Immunol       Date:  2015-01-28       Impact factor: 3.969

5.  Rictor deficiency in dendritic cells exacerbates acute kidney injury.

Authors:  Helong Dai; Alicia R Watson; Daniel Fantus; Longkai Peng; Angus W Thomson; Natasha M Rogers
Journal:  Kidney Int       Date:  2018-09-04       Impact factor: 10.612

6.  Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells.

Authors:  Roberta Castriconi; Claudia Cantoni; Mariella Della Chiesa; Massimo Vitale; Emanuela Marcenaro; Romana Conte; Roberto Biassoni; Cristina Bottino; Lorenzo Moretta; Alessandro Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

7.  IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells.

Authors:  Heth R Turnquist; Tina L Sumpter; Allan Tsung; Alan F Zahorchak; Atsunori Nakao; Gerard J Nau; Foo Y Liew; David A Geller; Angus W Thomson
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  Role of fatty-acid synthesis in dendritic cell generation and function.

Authors:  Adeel Rehman; Keith C Hemmert; Atsuo Ochi; Mohsin Jamal; Justin R Henning; Rocky Barilla; Juan P Quesada; Constantinos P Zambirinis; Kerry Tang; Melvin Ego-Osuala; Raghavendra S Rao; Stephanie Greco; Michael Deutsch; Suchithra Narayan; H Leon Pachter; Christopher S Graffeo; Devrim Acehan; George Miller
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

9.  Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity.

Authors:  Brian M Janelsins; Alicia R Mathers; Olga A Tkacheva; Geza Erdos; William J Shufesky; Adrian E Morelli; Adriana T Larregina
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

10.  Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.

Authors:  Dajing Xia; Shu Zheng; Weiping Zhang; Long He; Qingqing Wang; Jianping Pan; Lihuang Zhang; Jianli Wang; Xuetao Cao
Journal:  J Mol Med (Berl)       Date:  2003-08-21       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.